WO2005082459A3 - Procédé de réduction des globules sanguins - Google Patents

Procédé de réduction des globules sanguins Download PDF

Info

Publication number
WO2005082459A3
WO2005082459A3 PCT/JP2005/003682 JP2005003682W WO2005082459A3 WO 2005082459 A3 WO2005082459 A3 WO 2005082459A3 JP 2005003682 W JP2005003682 W JP 2005003682W WO 2005082459 A3 WO2005082459 A3 WO 2005082459A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood cells
decreasing blood
decreasing
subject
administering
Prior art date
Application number
PCT/JP2005/003682
Other languages
English (en)
Other versions
WO2005082459A2 (fr
Inventor
Kenji Fukui
Akemi Takahashi
Nobuyuki Tajima
Naofumi Uesato
Junji Maruhashi
Original Assignee
Japan Tobacco Inc
Kenji Fukui
Akemi Takahashi
Nobuyuki Tajima
Naofumi Uesato
Junji Maruhashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc, Kenji Fukui, Akemi Takahashi, Nobuyuki Tajima, Naofumi Uesato, Junji Maruhashi filed Critical Japan Tobacco Inc
Publication of WO2005082459A2 publication Critical patent/WO2005082459A2/fr
Publication of WO2005082459A3 publication Critical patent/WO2005082459A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L’invention propose un procédé de réduction du nombre de globules sanguins chez un patient en ayant besoin comprenant l’administration d’un composé de Formule (I) à un patient.
PCT/JP2005/003682 2004-02-27 2005-02-25 Procédé de réduction des globules sanguins WO2005082459A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54820304P 2004-02-27 2004-02-27
US60/548,203 2004-02-27

Publications (2)

Publication Number Publication Date
WO2005082459A2 WO2005082459A2 (fr) 2005-09-09
WO2005082459A3 true WO2005082459A3 (fr) 2006-09-28

Family

ID=34910995

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/003682 WO2005082459A2 (fr) 2004-02-27 2005-02-25 Procédé de réduction des globules sanguins

Country Status (1)

Country Link
WO (1) WO2005082459A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ748511A (en) * 2016-04-27 2023-05-26 Vladimir Badmaev Method maintaining iron homeostasis with shogaols

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1304322A2 (fr) * 1995-08-22 2003-04-23 Japan Tobacco Inc. Composé d'acide carboxylique et son utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1304322A2 (fr) * 1995-08-22 2003-04-23 Japan Tobacco Inc. Composé d'acide carboxylique et son utilisation

Also Published As

Publication number Publication date
WO2005082459A2 (fr) 2005-09-09

Similar Documents

Publication Publication Date Title
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2006113942A3 (fr) Procede d'inhibition de l'activite de cathepsine
WO2006053043A3 (fr) Methodes de traitement du diabete sucre
WO2004064755A3 (fr) Procedes d'inhibition d'un proteasome
AU2003901345A0 (en) Improved cannula
PL2572661T3 (pl) Stopniowana kaniula
EP1789129A4 (fr) Raccord de pompe cardiaque
EP1604989A8 (fr) Inhibiteurs de DPP-IV
WO2008019395A3 (fr) Composés pour améliorer l'apprentissage et la mémoire
HK1116099A1 (en) Medical tape preparation
WO2007099171A3 (fr) Bicyclopyrazoles actifs comme inhibiteurs de la kinase
WO2008021804A3 (fr) Amides thérapeutiques et composés associés
WO2008021975A3 (fr) Lactames thérapeutiques
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
EP1604980A8 (fr) Inhibiteurs de DPP-IV
WO2006036932A3 (fr) Sulfonamides et leurs utilisations
WO2006029398A8 (fr) Tout-trans-retinol:tout-trans-13,14-dihydroretinol saturase et procedes d'utilisation de cette enzyme
AU2005254779A8 (en) Well treatment
WO2008061671A3 (fr) Utilisation d'un acide indazoleméthoxyalcanoïque dans la préparation d'une composition pharmaceutique
WO2008023003A8 (fr) Associations médicamenteuses destinées au traitement de maladies des voies respiratoires
MX301967B (es) Formulaciones de glifosato de carga alta.
WO2006023586A3 (fr) Composes de guanylhydrazone, compositions de guanylhydrazone, ainsi que leurs methodes de fabrication
WO2005082459A3 (fr) Procédé de réduction des globules sanguins
WO2008028032A3 (fr) Hydantoïnes substituées, thérapeutiques, et composés associés
AU2003272198A1 (en) Storage of blood

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase